Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Klíčová slova:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideAbstrakt
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Stažení
Publikováno
2021-02-05
Číslo
Sekce
Review Article
Licence
Copyright (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema
Tato práce je licencována pod Mezinárodní licencí Creative Commons Attribution-NonCommercial 4.0.
Jak citovat
Phosphate Binders in CKD: ‟New Kids on the Block”. (2021). Pakistan Journal of Kidney Diseases, 3(10). https://doi.org/10.53778/pjkd31089
